000 01092 a2200325 4500
005 20250511150610.0
264 0 _c19790523
008 197905s 0 0 eng d
022 _a0013-7227
024 7 _a10.1210/endo-103-2-452
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKramer, J
245 0 0 _aProlactin suppression by (-) delta-9-tetrahydrocannabinol (THC): involvement of serotonergic and dopaminergic pathways.
_h[electronic resource]
260 _bEndocrinology
_cAug 1978
300 _a452-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCyproheptadine
_xpharmacology
650 0 4 _aDopamine
_xphysiology
650 0 4 _aDronabinol
_xpharmacology
650 0 4 _aMale
650 0 4 _aPerphenazine
_xpharmacology
650 0 4 _aPimozide
_xpharmacology
650 0 4 _aProlactin
_xblood
650 0 4 _aRats
650 0 4 _aSerotonin
_xphysiology
700 1 _aBen-David, M
773 0 _tEndocrinology
_gvol. 103
_gno. 2
_gp. 452-7
856 4 0 _uhttps://doi.org/10.1210/endo-103-2-452
_zAvailable from publisher's website
999 _c764433
_d764433